Patel S - Search Results

1

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®).

Marx N, Rosenstock J, Kahn SE, Zinman B, Kastelein JJ, Lachin JM, Espeland MA, Bluhmki E, Mattheus M, Ryckaert B, Patel S, Johansen OE, Woerle HJ. Marx N, et al. Among authors: patel s. Diab Vasc Dis Res. 2015 May;12(3):164-74. doi: 10.1177/1479164115570301. Epub 2015 Mar 15. Diab Vasc Dis Res. 2015. PMID: 25780262 Free PMC article. Clinical Trial.

2

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.

Johansen OE, Neubacher D, von Eynatten M, Patel S, Woerle HJ. Johansen OE, et al. Among authors: patel s. Cardiovasc Diabetol. 2012 Jan 10;11:3. doi: 10.1186/1475-2840-11-3. Cardiovasc Diabetol. 2012. PMID: 22234149 Free PMC article.

3

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.

Gallwitz B, Rosenstock J, Rauch T, Bhattacharya S, Patel S, von Eynatten M, Dugi KA, Woerle HJ. Gallwitz B, et al. Among authors: patel s. Lancet. 2012 Aug 4;380(9840):475-83. doi: 10.1016/S0140-6736(12)60691-6. Epub 2012 Jun 28. Lancet. 2012. PMID: 22748821 Clinical Trial.

4

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial.

Rosenstock J, Marx N, Kahn SE, Zinman B, Kastelein JJ, Lachin JM, Bluhmki E, Patel S, Johansen OE, Woerle HJ. Rosenstock J, et al. Among authors: patel s. Diab Vasc Dis Res. 2013 Jul;10(4):289-301. doi: 10.1177/1479164112475102. Epub 2013 Feb 28. Diab Vasc Dis Res. 2013. PMID: 23449634 Free article. Review.

5

Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment.

McGill JB, Barnett AH, Lewin AJ, Patel S, Neubacher D, von Eynatten M, Woerle HJ. McGill JB, et al. Among authors: patel s. Diab Vasc Dis Res. 2014 Jan;11(1):34-40. doi: 10.1177/1479164113507068. Epub 2013 Oct 29. Diab Vasc Dis Res. 2014. PMID: 24169807 Free article. Clinical Trial.

6

Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.

Lehrke M, Marx N, Patel S, Seck T, Crowe S, Cheng K, von Eynatten M, Johansen OE. Lehrke M, et al. Among authors: patel s. Clin Ther. 2014 Aug 1;36(8):1130-46. doi: 10.1016/j.clinthera.2014.06.008. Epub 2014 Jul 8. Clin Ther. 2014. PMID: 25015594 Free article.

7

Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial.

Laakso M, Rosenstock J, Groop PH, Barnett AH, Gallwitz B, Hehnke U, Tamminen I, Patel S, von Eynatten M, Woerle HJ. Laakso M, et al. Among authors: patel s. Diabetes Care. 2015 Feb;38(2):e15-7. doi: 10.2337/dc14-1684. Diabetes Care. 2015. PMID: 25614693 Clinical Trial. No abstract available.

8

Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.

Rosenstock J, Marx N, Neubacher D, Seck T, Patel S, Woerle HJ, Johansen OE. Rosenstock J, et al. Among authors: patel s. Cardiovasc Diabetol. 2015 May 21;14:57. doi: 10.1186/s12933-015-0215-2. Cardiovasc Diabetol. 2015. PMID: 25990013 Free PMC article.

9

Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.

Zinman B, Ahrén B, Neubacher D, Patel S, Woerle HJ, Johansen OE. Zinman B, et al. Among authors: patel s. Can J Diabetes. 2016 Feb;40(1):50-7. doi: 10.1016/j.jcjd.2015.06.010. Epub 2015 Oct 21. Can J Diabetes. 2016. PMID: 26474870 Clinical Trial.

10

Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trial.

Nauck MA, di Domenico M, Patel S, Kobe M, Toorawa R, Woerle HJ. Nauck MA, et al. Among authors: patel s. Diab Vasc Dis Res. 2016 Jul;13(4):286-98. doi: 10.1177/1479164116639229. Epub 2016 May 5. Diab Vasc Dis Res. 2016. PMID: 27190087 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,383 results

Search Page